Dysbiotic Intervention: Harnessing Intrinsic Human Defenses Via The Paneth Cell Secretome To Engineer The Microbiome.

Massively Parallel Single Cell Transcriptomics to Define Microbial-Regulated Host Circuits That Influence Colonic Inflammation.

Engineering Probiotic Organisms to Sense, Diagnose, and Treat Inflammation.

Induction of Therapeutic Regulatory T Cells by Parasite Products.

Sensing Luminal Contents By The Enteric Nervous System: Consequences For Gut Immunity.

Capitalizing on Galectin-1-Glycan Interactions for the Design of Novel Therapeutic Strategies in Inflammatory Bowel Diseases.

Prospective Double-Blind Diet Controlled Trial of Low Carbohydrate Diets in Pediatric Crohn’s Disease.

The Impact of Fermentable Carbohydrate Restriction (Low FODMAP Diet) on Functional Gut Symptoms, Gut Microbiota and Immunology in Patients With Crohn’s Disease.

Investigating the Role of Gut Microbiota Secondary Metabolism in IBD – a Path to Novel IBD Therapeutics.

Exploring The Therapeutic Potential Of MUC2, A Gut-Specific Mucin With Anti-Inflammatory Properties.